4//SEC Filing
Loh Evan 4
Accession 0000904454-21-000630
CIK 0001178711other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 7:29 PM ET
Size
6.9 KB
Accession
0000904454-21-000630
Insider Transaction Report
Form 4
Loh Evan
DirectorSee Remarks
Transactions
- Sale
Common Stock
2021-08-17$5.12/sh−33,931$173,727→ 1,000,360 total - Award
Common Stock
2021-08-16+75,000→ 1,034,291 total
Footnotes (3)
- [F1]Represents performance-based restricted stock units ("PRSUs") granted on July 31, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 16, 2021.
- [F2]Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $5.02 to $5.22. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.
Documents
Issuer
Paratek Pharmaceuticals, Inc.
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001622680
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 7:29 PM ET
- Size
- 6.9 KB